Docetaxel (Albumin Bound)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Docetaxel (Albumin Bound), covering 2022-10-13 to 2024-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer [Phase 2]